(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 6.96% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Gevo's revenue in 2026 is $177,507,000.On average, 8 Wall Street analysts forecast GEVO's revenue for 2026 to be $49,210,073,180, with the lowest GEVO revenue forecast at $42,969,808,675, and the highest GEVO revenue forecast at $54,805,048,844. On average, 8 Wall Street analysts forecast GEVO's revenue for 2027 to be $52,730,729,541, with the lowest GEVO revenue forecast at $44,868,589,634, and the highest GEVO revenue forecast at $59,287,457,539.
In 2028, GEVO is forecast to generate $53,123,836,536 in revenue, with the lowest revenue forecast at $44,947,705,507 and the highest revenue forecast at $60,988,448,815.